Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-104 in type 2 diabetes inadequately controlled on metformin
NCT00995345Phase 2Completed
- Sponsor
- ActivX Biosciences, Inc.
- Start
- Oct 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of besigliptin in type 2 diabetes mellitus (T2DM), sponsored by ActivX Biosciences, Inc.. Started Oct 2009; status: completed.
02
Drugs
besigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00995345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995345.